Bradley M. Nagel, serving as the Chief Financial Officer for Electromed, Inc. (NYSE American: ELMD), completed a transaction involving the sale of company equity on June 4, 2026. The disposition of shares resulted in approximately $428,936 in proceeds, as documented in a recent Securities and Exchange Commission filing. This executive activity takes place while the company's stock is trading at $37.08, a level situated close to its 52-week high of $40.00. The current valuation follows a substantial 77% appreciation in the stock price over the preceding twelve months.
Market analysis suggests the stock may currently trade above its intrinsic fair value, according to InvestingPro data. This assessment represents one of sixteen specific insights provided to subscribers. Investors seeking comprehensive valuation data for ELMD and over 1,400 other US equities can access detailed Pro Research Reports.
The sale transaction comprised the direct liquidation of 11,801 shares of Electromed common stock. The execution prices for these shares ranged from $36.04 to $37.21 per share. The transaction was executed in two distinct portions. The first portion involved the sale of 11,620 shares at a weighted average price of $36.3355, with individual share prices falling between $36.04 and $37.02. The second portion consisted of 181 shares sold at a weighted average price of $37.114, with individual prices ranging from $37.055 to $37.21.
In a simultaneous development on the same date, Mr. Nagel acquired 9,601 additional shares of Electromed common stock through the exercise of employee stock options. The acquisition cost totaled approximately $100,833. The exercise prices for these options ranged from $10.25 to $10.71. Specifically, 4,334 options were exercised at a price of $10.25, and 5,267 options were exercised at a price of $10.71. Remaining options granted to the executive are scheduled to vest and become exercisable on June 30, 2026.
Following the completion of these transactions, Mr. Nagel's direct ownership of Electromed common stock stands at 19,638 shares.
The executive activity coincides with the release of Electromed's financial results for the third quarter of fiscal year 2026. The company reported an earnings per share of $0.35, significantly surpassing the analyst consensus forecast of $0.24. This performance generated an earnings surprise of 45.83%. Revenue for the quarter reached $18.6 million, also exceeding the expected figure of $17.82 million. These financial metrics indicate a strong operational performance for the company during this period.
The announcement of these results was followed by a notable increase in the company's stock value. The data reflects Electromed's capacity to exceed market expectations. The stock was reported at $37.08, reflecting a decline of $0.61 or 1.62% at close. After-hours trading showed the stock at $37.08 with no change.